Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Controlled Release

• Publication date

  2014-03-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2013.12.034PMID 24412572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo biodistribution and toxicology of carboxylated graphene quantum dots.

  2013cited by this paper
• Approaches for enhancing oral bioavailability of peptides and proteins.

  2013cited by this paper
• Near infra-red photoluminescent graphene nanoparticles greatly expand their use in noninvasive biomedical imaging.

  2013cited by this paper
• GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy.

  2013cited by this paper
• Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy.

  2013cited by this paper
• Surface coating of graphene quantum dots using mussel-inspired polydopamine for biomedical optical imaging.

  2013cited by this paper
• Heparin based nanoparticles for cancer targeting and noninvasive imaging.

  2012cited by this paper
• Imaging of the GI tract by QDs loaded heparin-deoxycholic acid (DOCA) nanoparticles.

  2012cited by this paper
• Oral delivery of near-infrared quantum dot loaded micelles for noninvasive biomedical imaging.

  2012cited by this paper
• Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.

  2012cited by this paper
• Blood compatible graphene/heparin conjugate through noncovalent chemistry.

  2011cited by this paper
• New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: synthesis, characterization and in vitro drug delivery response.

  2010cited by this paper
• Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy.

  2010cited by this paper
• Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.

  2010cited by this paper
• Ternary biomolecular nanoparticles for targeting of cancer cells and anti-angiogenesis.

  2010cited by this paper
• Computational oral absorption simulation of free base drugs.

  2010cited by this paper
• Targeted near-IR QDs-loaded micelles for cancer therapy and imaging.

  2010cited by this paper
• Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

  2009cited by this paper
• Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.

  2009cited by this paper
• Drug Delivery Technologies: The Way Forward in the New Decade

  2009cited by this paper
• Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties

  2009cited by this paper
• In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer.

  2009cited by this paper
• Bile acid transporters

  2009cited by this paper
• Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles.

  2008cited by this paper
• Antiangiogenic and Apoptotic Properties of a Novel Amphiphilic Folate-Heparin-Lithocholate Derivative Having Cellular Internality for Cancer Therapy

  2007cited by this paper
• Estimating drug solubility in the gastrointestinal tract.

  2007cited by this paper
• Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.

  2007cited by this paper
• Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer.

  2006cited by this paper
• Oral delivery of macromolecular drugs

  2006cited by this paper
• Drug/device combinations for local drug therapies and infection prophylaxis.

  2006cited by this paper
• Formulation aspects in the development of osmotically controlled oral drug delivery systems.

  2002cited by this paper
• Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal.

  2001cited by this paper
• Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

  2001cited by this paper
• Conjugation of Low-Molecular-Weight Heparin and Deoxycholic Acid for the Development of a New Oral Anticoagulant Agent

  2001cited by this paper
• Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

  2001cited by this paper
• Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.

  2000cited by this paper
• Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

  1999cited by this paper
• In Vitro-In Vivo Evaluation of a Controlled Release Buccal Bioadhesive Device for Oral Drug Delivery

  1999cited by this paper
• W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: biological activity after oral administration to normal and diabetic rats

  1998cited by this paper
• Review of theoretical passive drug absorption models: historical background, recent developments and limitations.

  1996cited by this paper
• The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

  1995cited by this paper
• Absorption of drugs from the human oral cavity

  1991cited by this paper
• Gel-matrixsystems exhibiting bimodal controlled release for oral drug delivery

  1989cited by this paper
• Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

  1988cited by this paper
• Present and future applications of biomaterials in controlled drug delivery systems.

  1981cited by this paper

• Xylo-oligosaccharide supplementation exacerbates colitis susceptibility in mice via taurine depletion

  2026cites this paper
• Bile Acid–Targeted Hyaluronic Acid Nanoparticles for Enhanced Oral Absorption of Deferoxamine

  2024cites this paper
• Nanoparticle-Based Interventions for Polycystic Ovary Syndrome: A Review of Mechanisms and Therapeutic Potential

  2024cites this paper
• Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice.

  2023cites this paper
• Promoting oral absorption of Panax notoginseng saponins via thiolated trimethyl chitosan and wheat germ agglutinin–modified nanoformulation

  2023cites this paper
• Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel

  2023cites this paper
• β-Glucan and Fatty Acid Based Mucoadhesive Carrier for Gastrointestinal Tract Specific Local and Sustained Drug Delivery.

  2023cites this paper
• Transporter-Mediated Drug Delivery

  2023influential citation
• Mechanism of Enhanced Oral Absorption of a Nano-Drug Delivery System Loaded with Trimethyl Chitosan Derivatives

  2022cites this paper
• Research Progress of Bile Acids in Cancer

  2022cites this paper
• Myofibroblast specific targeting approaches to improve fibrosis treatment.

  2022cites this paper
• Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs

  2022cites this paper
• Mucoadhesive carriers for oral drug delivery.

  2022cites this paper
• Engineering of Smart Nanoconstructs for Delivery of Glucagon-like Peptide-1 Analogs.

  2021cites this paper
• Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules

  2021cites this paper
• Nanotechnology for angiogenesis: opportunities and challenges.

  2020cites this paper
• Bile acid transporter mediated STC/Soluplus self-assembled hybrid nanoparticles for enhancing the oral drug bioavailability.

  2020cites this paper
• Non-anticoagulant heparin as a pre-exposure prophylaxis prevents Lyme disease infection.

  2020cites this paper
• Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems.

  2020cites this paper
• Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF‐κB signaling pathway in vitro

  2019cites this paper
• Dynamic contrast enhanced‑magnetic resonance imaging for the early evaluation of the response to docetaxel in rats with epithelial ovarian cancer.

  2019cites this paper
• A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels.

  2019cites this paper
• Current advances in development of new docetaxel formulations

  2019cites this paper
• Cholate-modified polymer-lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect

  2019cites this paper
• Heparin-Based Nanoparticles: An Overview of Their Applications

  2018cites this paper
• Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.

  2018cites this paper
• Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids

  2018cites this paper
• Folate and Borneol Modified Bifunctional Nanoparticles for Enhanced Oral Absorption

  2018cites this paper
• Emerging transporter-targeted nanoparticulate drug delivery systems

  2018cites this paper
• Oral delivery of a therapeutic gene encoding glucagon‐like peptide 1 to treat high fat diet‐induced diabetes

  2017cites this paper
• Loading docetaxel in β-cyclodextrin-based micelles for enhanced oral chemotherapy through inhibition of P-glycoprotein mediated efflux transport

  2017cites this paper
• Polysaccharide based nano/microformulation: an effective and versatile oral drug delivery system

  2017cites this paper
• Oral siRNA Delivery to Treat Colorectal Liver Metastases.

  2017cites this paper
• Oral Gavage Delivery of PR8 Antigen with β-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity.

  2017cites this paper
• Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers

  2017cites this paper
• Animal models for evaluation of oral delivery of biopharmaceuticals

  2017cites this paper
• The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.

  2017cites this paper
• Design and strategies for bile acid mediated therapy and imaging

  2016cites this paper
• Nanobiomaterial-based delivery of drugs in various cancer therapies

  2016cites this paper
• Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.

  2016cites this paper
• Strategies to Overcome Heparins’ Low Oral Bioavailability

  2016cites this paper
• The Effect of Hydrophilic and Hydrophobic Structure of Amphiphilic Polymeric Micelles on Their Transportation in Rats.

  2016cites this paper
• Poly-ion Complex of Chondroitin Sulfate and Spermine and Its Effect on Oral Chondroitin Sulfate Bioavailability.

  2016cites this paper
• Chrysin-organogermanium (IV) complex induced Colo205 cell apoptosis-associated mitochondrial function and anti-angiogenesis.

  2015cites this paper
• Polysaccharide Colloids as Smart Vehicles in Cancer Therapy.

  2015cites this paper
• Surface-Eroding Poly(ortho ester amides) for Highly Efficient Oral Chemotherapy.

  2015cites this paper
• A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin.

  2015cites this paper
• Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery

  2015influential citation
• Photoluminescent graphene nanoparticles for cancer phototherapy and imaging.

  2014cites this paper